ICAHN School of Medicine At Mount Sinai
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1963-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mssm.edu
Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
- Conditions
- Traumatic Brain InjuryFatigue
- Interventions
- Device: Bright White Light (BWL)Device: Dim Red Light (DRL)
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 88
- Registration Number
- NCT01725750
- Locations
- 🇺🇸
The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai, New York, New York, United States
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
- Conditions
- ADHDAttention Deficit Hyperactivity Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 27
- Registration Number
- NCT01709695
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
- Conditions
- Squamous Cell Carcinomas
- Interventions
- First Posted Date
- 2012-10-15
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 23
- Registration Number
- NCT01706939
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Riluzole in Mild Alzheimer's Disease
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 50
- Registration Number
- NCT01703117
- Locations
- 🇺🇸
The Rockefeller University, New York, New York, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
- Conditions
- X-Linked ProtoporphyriaXLPErythropoietic ProtoporphyriaEPPXLEPPXLDPXLPPX-Linked Dominant Erythropoietic Protoporphyria
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 150
- Registration Number
- NCT01688895
- Locations
- 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
- Conditions
- Attention Deficit Hyperactivity DisorderADHD
- Interventions
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2020-07-24
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 127
- Registration Number
- NCT01678209
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 11
- Registration Number
- NCT01658150
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department
- Conditions
- Pneumonia
- Interventions
- Radiation: Chest X-RayOther: Lung Ultrasound
- First Posted Date
- 2012-08-01
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 191
- Registration Number
- NCT01654887
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Equity in Diagnostic Imaging Trial
- Conditions
- Headache
- Interventions
- Other: Audit-feedbackOther: Clinical Decision Support
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 181
- Registration Number
- NCT01611714
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
- Conditions
- Dual Antiplatelet TherapyAspirinPercutaneous Coronary InterventionClopidogrel
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 318
- Registration Number
- NCT01582217
- Locations
- 🇺🇸
Mount Sinai Medical Center, New York, New York, United States